Virus-Immunotherapy combo targets Hard-to-Treat cancers
NCT ID NCT05165433
First seen Jan 07, 2026 · Last updated May 15, 2026 · Updated 19 times
Summary
This early-phase study tested a new treatment called NG-350A, a virus designed to activate immune cells inside tumors, combined with the immunotherapy drug pembrolizumab. It involved 14 people with advanced epithelial cancers that had stopped responding to standard treatments. The main goal was to check the safety and tolerability of this combination.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Churchill Hospital, Oxford University Hospitals NHS Foundation Trust
Oxford, Oxfordshire, OX3 7LE, United Kingdom
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
Moffitt-Advent Health Clinical Research Unit
Celebration, Florida, 34747, United States
-
Perelman Center of Advanced Medicine
Philadelphia, Pennsylvania, 19104, United States
-
Providence Medical Foundation
Santa Monica, California, 90404, United States
-
The Clatterbridge Cancer Centre NHS Foundation Trust
Liverpool, Lancashire, L7 8YA, United Kingdom
-
UCLA
Santa Monica, California, 90404, United States
Conditions
Explore the condition pages connected to this study.